The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer

Autor: Epstein, JI, Amin, MB, Fine, SW, Algaba, F, Aron, M, Baydar, DE, Beltran, AL, Brimo, F, Cheville, JC, Colecchia, M, Comperat, E, da Cunha, IW, Delprado, W, DeMarzo, AM, Giannico, GA, Gordetsky, JB, Guo, CC, Hansel, DE, Hirsch, MS, Huang, JT, Humphrey, PA, Jimenez, RE, Khani, F, Kong, QN, Kryvenko, ON, Kunju, LP, Lal, P, Latour, M, Lotan, T, Maclean, F, Magi-Galluzzi, C, Mehra, R, Menon, S, Miyamoto, H, Montironi, R, Netto, GJ, Nguyen, JK, Osunkoya, AO, Parwani, A, Robinson, BD, Rubin, MA, Shah, RB, So, JS, Takahashi, H, Tavora, F, Tretiakova, MS, True, L, Wobker, SE, Yang, XMJ, Zhou, M, Zynger, DL, Trpkov, K

Publikováno v: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Context.-Controversies and uncertainty persist in prostate cancer grading. prostate cancer grading. Objective.-To update grading recommendations Data Sources.-Critical review of the literature along with pathology and clinician surveys. Conclusions.-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::76c321c06ce974534b3f9b7f1511bbfa
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4835

Predicting Response to Intravesical BCG in High-Risk NMIBC Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.

Autor: Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Krishna V; Valar Labs, Palo Alto, California., Abuzeid WM; Valar Labs, Palo Alto, California., Launer B; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Chang SS; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Krishna V; Valar Labs, Palo Alto, California., Shingi S; Valar Labs, Palo Alto, California., Gordetsky JB; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Gerald T; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Woldu S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Shkolyar E; Department of Urology, Stanford Medicine, Palo Alto, California., Hayne D; Department of Urology, University of Western Australia, Perth, Australia., Redfern A; Department of Medical Oncology, University of Western Australia, Perth, Australia., Spalding L; Department of Urology, University of Western Australia, Perth, Australia., Stewart C; Department of Urology, University of Texas Medical Branch, Galveston, Texas., Eyzaguirre E; Department of Pathology, University of Texas Medical Branch, Galveston, Texas., Imtiaz S; Department of Urology, Emory University School of Medicine, Atlanta, Georgia., Narayan VM; Department of Urology, Emory University School of Medicine, Atlanta, Georgia., Packiam VT; Department of Urology, University of Iowa, Iowa City, Iowa., O'Donnell MA; Department of Urology, University of Iowa, Iowa City, Iowa., Li R; Department of Urology, Moffitt Cancer Center, Tampa, Florida., Baekelandt L; Department of Urology, UZ Leuven, Leuven, Belgium., Joniau S; Department of Urology, UZ Leuven, Leuven, Belgium., Zuiverloon T; Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands., Fernandez MI; Department of Urology, Clínica Alemana Universidad del Desarrollo, Santiago, Chile., Schultz M; Department of Pathology, Clínica Alemana Universidad del Desarrollo, Santiago, Chile., Hensley PJ; Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky., Allison D; Department of Pathology, University of Kentucky College of Medicine, Lexington, Kentucky., Taylor JA; Department of Urology, University of Kansas Medical Center, Kansas City, Kansas., Hamza A; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas., Kamat A; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Nimgaonkar V; Valar Labs, Palo Alto, California., Sonawane S; Valar Labs, Palo Alto, California., Miller DL; Valar Labs, Palo Alto, California., Watson D; Valar Labs, Palo Alto, California., Vrabac D; Valar Labs, Palo Alto, California., Joshi A; Valar Labs, Palo Alto, California., Shah JB; Department of Urology, Stanford Medicine, Palo Alto, California., Williams SB; Department of Urology, University of Texas Medical Branch, Galveston, Texas.

Publikováno v: The Journal of urology [J Urol] 2024 Oct 09, pp. 101097JU0000000000004278. Date of Electronic Publication: 2024 Oct 09.

Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.

Autor: Fahey CC; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Tennessee Valley Healthcare System, Veterans' Affairs, Nashville, TN 37232, USA., Nebhan CA; Intermountain Health, Murry, UT 84107, USA., York S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Tennessee Valley Healthcare System, Veterans' Affairs, Nashville, TN 37232, USA.; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Davis NB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Hurley PJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.; Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Gordetsky JB; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.; Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Schaffer KR; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 09; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 09.

Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms.

Autor: Yu S; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Siegmund S; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Ulbright TM; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Collins K; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Colecchia M; Department of Pathology, Vita- Salute San Raffaele University, Milan, Italy., Del Pilar Gonzalez-Peramato M; Department of Pathology, La Paz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Michalová K; Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic., Gordetsky JB; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Cornejo KM; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Kao CS; Department of Pathology, Stanford University, Stanford, CA, USA., Wobker SE; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Vargas SO; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Maclean F; Douglass Hanly Moir Pathology, Macquarie University, Sydney, Australia., Idrees MT; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Anderson WJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Acosta AM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Publikováno v: Histopathology [Histopathology] 2023 Jun; Vol. 82 (7), pp. 1079-1088. Date of Electronic Publication: 2023 Mar 16.

Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification.

Autor: Siegmund SE; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Tsai HK; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Yang Y; Department of Pathology, NYU Langone Health, New York, NY, USA., Vasudevaraja V; Department of Pathology, NYU Langone Health, New York, NY, USA., Tran I; Department of Pathology, NYU Langone Health, New York, NY, USA., Snuderl M; Department of Pathology, NYU Langone Health, New York, NY, USA., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Cornejo KM; Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA., Idrees MT; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Al-Obaidy KI; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Collins K; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA., Gordetsky JB; Department of Pathology, Vanderbilt University Medical Center/Vanderbilt University, Nashville, TN, USA., Wobker SE; Department of Pathology, University of North Carolina Medical Center/University of North Carolina, Chapel Hill, NC, USA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Trpkov K; Department of Pathology, Rockyview General Hospital/University of Calgary, Calgary, AB, Canada., Yilmaz A; Department of Pathology, Rockyview General Hospital/University of Calgary, Calgary, AB, Canada., Anderson WJ; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA., Quiroga-Garza G; Department of Pathology, University of Pittsburgh Medical Center Shadyside, Pittsburgh, PA, USA., Magi-Galluzzi C; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, UK., Canete-Portillo S; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, UK., Acosta AM; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA. aacosta4@bwh.harvard.edu.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Dec; Vol. 35 (12), pp. 1944-1954. Date of Electronic Publication: 2022 Sep 30.